These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

62 related articles for article (PubMed ID: 1622431)

  • 21. Therapeutic effect of the quinolone prodrug prulifloxacin against experimental urinary tract infections in mice.
    Tomii Y; Ozaki M; Matsuda M; Honmura T; Nishimura I; Yamaguchi R; Adachi T; Okawa Y; Nishino T
    Arzneimittelforschung; 1996 Dec; 46(12):1169-73. PubMed ID: 9006794
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mutation rates to 4-quinolone resistance.
    Smith JT
    Arzneimittelforschung; 1990 Jan; 40(1):65-8. PubMed ID: 2111135
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Randomized, double-blind, comparative study of levofloxacin and ofloxacin in the treatment of complicated urinary tract infections.
    Peng MY
    J Microbiol Immunol Infect; 1999 Mar; 32(1):33-9. PubMed ID: 11561568
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Photoreactivity of biologically active compounds. XVIII. Photostability of ofloxacin in the solid state and in a tablet formulation.
    Tønnesen HH; Brunsvik A; Løseth K; Bergh K; Gederaas OA
    Pharmazie; 2007 Feb; 62(2):105-11. PubMed ID: 17341028
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Use of ofloxacin in the treatment of suppurative-inflammatory complications in surgery].
    Bogomolova NS; Bol'shakov LV; Vinogradova LN; Sorokina VI; Oreshkina TD; Tret'iakova ES
    Anesteziol Reanimatol; 1997; (3):18-20. PubMed ID: 9289979
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Ofloxacin as the standard 4-quinolone in sensitivity tests.
    Amyes SG; Paton RH; Miles RS; Hood J
    J Antimicrob Chemother; 1992 Jul; 30(1):101-2. PubMed ID: 1429327
    [No Abstract]   [Full Text] [Related]  

  • 27. Addressing the stability of C-capped dipeptide efflux pump inhibitors that potentiate the activity of levofloxacin in Pseudomonas aeruginosa.
    Renau TE; Léger R; Flamme EM; She MW; Gannon CL; Mathias KM; Lomovskaya O; Chamberland S; Lee VJ; Ohta T; Nakayama K; Ishida Y
    Bioorg Med Chem Lett; 2001 Mar; 11(5):663-7. PubMed ID: 11266165
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [The efficacy of using Zanocin in infectious diseases].
    Rudenko AA; Shapiro AV; Kononenko VV; Muravskaia LV; Diadiun ST; Okruzhnov NV; Sidorova ZhP
    Lik Sprava; 1996; (3-4):140-3. PubMed ID: 9035852
    [No Abstract]   [Full Text] [Related]  

  • 29. [A new antibiotic: levofloxacine].
    Douadi Y; Lescure X; Schmit JL
    Presse Med; 2000 Jun; 29(21):1184-5. PubMed ID: 10906942
    [No Abstract]   [Full Text] [Related]  

  • 30. New quinolones, ofloxacin and levofloxacin, inhibit telomerase activity in transitional cell carcinoma cell lines.
    Yamakuchi M; Nakata M; Kawahara K; Kitajima I; Maruyama I
    Cancer Lett; 1997 Nov; 119(2):213-9. PubMed ID: 9570374
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of bile duct ligation and unilateral nephrectomy on brain concentration and convulsant potential of the quinolone antibacterial agent levofloxacin in rats.
    Akahane K; Ohkawara S; Nomura M; Kato M
    Fundam Appl Toxicol; 1996 Feb; 29(2):280-6. PubMed ID: 8742326
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [[New antimicrobial agent series XLVII]: levofloxacin].
    Saito A
    Jpn J Antibiot; 1994 Apr; 47(4):309-32. PubMed ID: 8201762
    [No Abstract]   [Full Text] [Related]  

  • 33. Low incidence of quinolone resistance in gram-negative bacteria after five-years use of ofloxacin in prophylaxis during afebrile neutropenia.
    Kunova A; Trupl J; Krcmery V
    J Hosp Infect; 1996 Feb; 32(2):155-6. PubMed ID: 8666766
    [No Abstract]   [Full Text] [Related]  

  • 34. Diagnosis of quinolone-induced arthropathy in juvenile dogs by use of magnetic resonance (MR) imaging.
    Yabe K; Yoshida K; Yamamoto N; Nishida S; Ohshima C; Sekiguchi M; Yamada K; Furuhama K
    J Vet Med Sci; 1997 Jul; 59(7):597-9. PubMed ID: 9271457
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Lack of chondrotoxicity of ofloxacin otic solution on the auditory ossicle cartilages of juvenile guinea pigs.
    Kato M; Akahane K; Shimoda K
    J Antimicrob Chemother; 1997 Feb; 39(2):269-71. PubMed ID: 9069552
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Ofloxacin alters expression of integrins on chondrocytes from mouse fetuses in vitro.
    Shakibaei M; Förster C; Merker HJ; Stahlmann R
    Drugs; 1995; 49 Suppl 2():293-5. PubMed ID: 8549338
    [No Abstract]   [Full Text] [Related]  

  • 37. [Fleroxacin--a new quinolone antibiotic].
    Kostić D
    Vojnosanit Pregl; 1996; 53(4):311-24. PubMed ID: 9229948
    [No Abstract]   [Full Text] [Related]  

  • 38. Expression of beta 1-integrins on epiphyseal chondrocytes is reduced by ofloxacin.
    Förster C; Shakibaei M; Schilcher H; Stahlmann R
    Drugs; 1995; 49 Suppl 2():279-82. PubMed ID: 8549332
    [No Abstract]   [Full Text] [Related]  

  • 39. The developmental toxicity of three antimicrobial agents observed only in nonroutine animal studies.
    Stahlmann R; Chahoud I; Thiel R; Klug S; Förster C
    Reprod Toxicol; 1997; 11(1):1-7. PubMed ID: 9138627
    [No Abstract]   [Full Text] [Related]  

  • 40. Immunomodulation by antibacterial agents. Is it clinically relevant?
    Labro MT
    Drugs; 1993 Mar; 45(3):319-28. PubMed ID: 7682903
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.